NTLA
Intellia Therapeutics Inc.
$24.23
-$0.29(-1.18%)
69
Overall
60
Value
100
Tech
47
Quality
Market Cap
$2.19B
Volume
5.85M
52W Range
$5.90 - $26.99
Target Price
$33.46
EPS Estimates Overview
| Current Quarter | $-1 | Next Quarter | $-0.99 |
| Current Year | $-4.09 | Next Year | $-3.97 |
| QoQ Growth | +1.0% | YoY Growth | +2.9% |
| 3Y EPS CAGR | +0.0% | Target Price | $33.46 |
| Consensus | Buy | Upside | +38.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NTLA | $24.23 | -1.2% | 5.85M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Intellia Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW